Clinical Trial Update: CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing conditioning with cytoablative chemotherapy (CBA) versus family-blood-availability (FBA) conditioning followed by haploidenti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CBA conditioning
• FBA conditioning

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation | Phase 3 | Status: UNKNOWN